Annual report pursuant to Section 13 and 15(d)
Cover
Document and Entity Information
Financial Statements
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS (Parenthetical)
CONSOLIDATED STATEMENTS OF OPERATIONS
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)
CONSOLIDATED STATEMENTS OF CASH FLOWS
Notes to Financial Statements
DESCRIPTION OF BUSINESS
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
CONCENTRATIONS OF BUSINESS AND CREDIT RISK
VARIABLE INTEREST ENTITY ARRANGEMENTS
ACQUISITIONS
NOTES RECEIVABLE
INVENTORY
PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS, NET
INTANGIBLE ASSETS, NET
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
NOTES PAYABLE
CONTINGENT CONSIDERATION
FAIR VALUE MEASUREMENTS
TAX EXPENSE
EQUITY
STOCK-BASED COMPENSATION
WARRANTS
COMMITMENTS AND CONTINGENCIES
SELECTED QUARTERLY FINANCIAL DATA (Unaudited)
SEGMENT INFORMATION
LITIGATION AND CLAIMS
RELATED PARTY TRANSACTIONS
SUBSEQUENT EVENTS
Accounting Policies
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
VARIABLE INTEREST ENTITY ARRANGEMENTS (Tables)
ACQUISITIONS (Tables)
INVENTORY (Tables)
PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS, NET (Tables)
INTANGIBLE ASSETS, NET (Tables)
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)
NOTES PAYABLE (Tables)
CONTINGENT CONSIDERATION LIABILITY (Tables)
FAIR VALUE MEASUREMENTS (Tables)
TAX EXPENSE (Tables)
STOCK-BASED COMPENSATION (Tables)
WARRANTS (Tables)
COMMITMENTS AND CONTINGENCIES (Tables)
SELECTED QUARTERLY FINANCIAL DATA (Unaudited) (Tables)
SEGMENT INFORMATION (Tables)
Notes Details
DESCRIPTION OF BUSINESS (Details Narrative)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
CONCENTRATIONS OF BUSINESS AND CREDIT RISK (Details Narrative)
VARIABLE INTEREST ENTITY ARRANGEMENTS (Details Narrative)
ACQUISITIONS (Details)
ACQUISITIONS (Details 1)
ACQUISITIONS (Details 2)
ACQUISITIONS (Details 3)
ACQUISITIONS (Details 4)
ACQUISITIONS (Details Narrative)
NOTES RECEIVABLE (Details Narrative)
INVENTORY (Details)
PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS, NET(Details)
PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS, NET (Details Narrative)
INTANGIBLE ASSETS, NET (Details)
INTANGIBLE ASSETS, NET (Details 1)
INTANGIBLE ASSETS, NET (Details Narrative)
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)
NOTES PAYABLE (Details)
NOTES PAYABLE (Details 1)
NOTES PAYABLE (Details 2)
NOTES PAYABLE (Details Narrative)
CONTINGENT CONSIDERATION LIABILITY (Details)
CONTINGENT CONSIDERATION LIABILITY (Details 1)
CONTINGENT CONSIDERATION LIABILITY (Details 2)
CONTINGENT CONSIDERATION LIABILITY (Details 3)
CONTINGENT CONSIDERATION LIABILITY (Details 4)
CONTINGENT CONSIDERATION LIABILITY (Details 5)
CONTINGENT CONSIDERATION LIABILITY (Details Narrative)
FAIR VALUE MEASUREMENTS (Details)
FAIR VALUE MEASUREMENTS (Details 1)
FAIR VALUE MEASUREMENTS (Details 2)
FAIR VALUE MEASUREMENTS (Details 3)
TAX EXPENSE (Details)
TAX EXPENSE (Details 1)
TAX EXPENSE (Details 3)
TAX EXPENSE (Details Narrative)
EQUITY (Details Narrative)
STOCK-BASED COMPENSATION (Details)
STOCK-BASED COMPENSATION (Details 1)
STOCK-BASED COMPENSATION (Details 2)
STOCK-BASED COMPENSATION (Details 3)
STOCK-BASED COMPENSATION (Details Narrative)
WARRANTS (Details)
WARRANTS (Details 1)
WARRANTS (Details 2)
WARRANTS (Details 3)
WARRANTS (Details Narrative)
COMMITMENTS AND CONTINGENCIES (Details)
COMMITMENTS AND CONTINGENCIES (Details Narrative)
SELECTED QUARTERLY FINANCIAL DATA (Unaudited) (Details)
SEGMENT INFORMATION (Details)
RELATED PARTY TRANSACTIONS (Details Narrative)
SUBSEQUENT EVENTS (Details Narrative)
CONTINGENT CONSIDERATION LIABILITY (Details)
v3.8.0.1
CONTINGENT CONSIDERATION LIABILITY (Details)
12 Months Ended
Dec. 31, 2017
Therapeutics Medical Acquisition[Member]
Formula to calculate contingent consideration, description
One-Year Anniversary Date Revenue
Probability
Revenue-Based
Payment
Probability-Weighted
Amounts
$
3,200,000
0.00
%
$
800,000
$
$
2,000,000
0.50
%
$
200,000
1,000
$
1,599,999
99.50
%
$
Fair Value of Expected Earn-out Payment
1,000
Discount Rate
25
%
Payments
$
0
Present Value Factor at 20% Discount Rate for 12 Months
0.9457
Present Value of Contingent Consideration
S
946
X
- References
No definition available.
+ Details
Name:
TRTCD_FormulaToCalculateContingentConsiderationDescription
Namespace Prefix:
TRTCD_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
us-gaap_BusinessAcquisitionAxis=TRTCD_TherapeuticsMedicalAcquisitionMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type: